Publikationen in Zusammenarbeit mit Forschern von Hospital General Universitario de Elche (9)

2024

  1. Corrigendum: Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum(Front. Med., (2023), 10, (1156557.), 10.3389/fmed.2023.1156557)

    Frontiers in Medicine

  2. Exosomal Osteoclast-Derived miRNA in Rheumatoid Arthritis: From Their Pathogenesis in Bone Erosion to New Therapeutic Approaches

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Analysis of Novel Immunological Biomarkers Related to Rheumatoid Arthritis Disease Severity

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  2. Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis

    Frontiers in Medicine, Vol. 10

  3. Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum

    Frontiers in Medicine, Vol. 10

2015

  1. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism

2014

  1. Tocilizumab en pacientes con artritis reumatoide activa y respuesta inadecuada a fármacos antirreumáticos modificadores de la enfermedad o antagonistas del factor de necrosis tumoral: Subanálisis de los datos españoles de un estudio abierto cercano a la práctica clínica habitual

    Reumatologia Clinica, Vol. 10, Núm. 2, pp. 94-100

2013

  1. Negative effect of immunosuppressive therapy in the performance of the QuantiFERON Gold In-Tube test in patients with immune-mediated inflammatory diseases

    Clinical and Experimental Medicine, Vol. 13, Núm. 3, pp. 177-186

2009

  1. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to Disease Activity Score-28

    Autoimmunity, Vol. 42, Núm. 8, pp. 636-645